# Vaccine Responsiveness After CAR-T Cell Therapy

> **NCT04410900** · PHASE1 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 49 (actual)

## Conditions studied

- B-Cell Neoplasm

## Interventions

- **BIOLOGICAL:** Wistar Rabies Virus Strain PM-1503-3M Vaccine
- **PROCEDURE:** Biospecimen Collection

## Key facts

- **NCT ID:** NCT04410900
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-03
- **Primary completion:** 2025-04-28
- **Final completion:** 2025-08-31
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410900, "Vaccine Responsiveness After CAR-T Cell Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04410900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*